Alkermes - PharmaKB

Alkermes(ALKS)

Alkermes plc is a pharmaceutical company that focuses on central nervous system (CNS) diseases like schizophrenia, bipolar disorder, depression, addiction and multiple sclerosis. The company was founded in 1987 by Michael Wall. In September 2011 Alkermes, Inc. merged with Elan Drug Technologies (EDT), the former drug formulation and manufacturing division of Élan Corporation, plc. The company is headquartered in Dublin, and has an R&D center in Waltham, Massachusetts, and manufacturing facilities in Athlone, Ireland, and Wilmington, Ohio.

Trade Name	Drug Name	Approved	Patent Expires	Indication
Aristada	Aripiprazole lauroxil	2015-10-05	2030-2039	Schizophrenia , Schizophrenia spectrum and other psychotic disorders
Isosorbide	Isosorbide	1998-09-22		Heart failure , Coronary disease , Angina pectoris , Gastroesophageal reflux , Diffuse esophageal spasm , Poisoning , Cyanosis , Pulmonary hypertension , Malignant hypertension
Ketoprofen	Ketoprofen	1997-12-10		Rheumatoid arthritis , Osteoarthritis , Dysmenorrhea
Lybalvi	Olanzapine, Samidorphan l-malate	2021-05-28	2025-2041	Schizophrenia, Psychotic disorders, Bipolar disorder, Schizophrenia spectrum and other psychotic disorders, Bulimia, Panic disorder, Major depressive disorder, Obsessive-compulsive disorder
Vivitrol	Naltrexone	2006-04-13	2024-2034	Obesity, Alcoholism, Opioid-related disorders, Tobacco use disorder, Overweight, Drug overdose, Attention deficit disorder with hyperactivity, Depressive disorder, Dyspnea, Intractable pain, Postoperative pain